Welcome to BioReagent Hub Hotline:19920083827
Article Detail

Impact Assessment of Fetal Bovine Serum Batch Differences and Cell Culture Quality Control Strategies

2026-09-22 02:45 Author:ABIOP Source:AI 生成 Views 193
Back to List
Impact Assessment of Fetal Bovine Serum Batch Differences and Cell Culture Quality Control Strategies

I. Why are batch differences worthy of attention?

Fetal bovine serum is a natural additive with complex components in cell culture. The differences between batches are mainly due to the geography, season, age, collection technology, filtration and sterilization of the donor cattle.Even for products of the same brand and origin, there may be certain fluctuations in protein composition, trace elements, hormone levels, endotoxin content, etc. in different batches.For sensitive systems such as adherent cells, primary cells, or stem cells, this difference may manifest as changes in proliferation rate, morphology, differentiation status, or even gene expression profile.

Therefore, it is not strict to regard fetal bovine serum as a "ready-to-use standard reagent".Establishing a batch difference recognition and management process is the basis for ensuring the reproducibility of cell experimental data.

II. Common Assessment Indicators

Appearance and physical and chemical indicators: color, clarity, total protein content, hemoglobin, endotoxin, etc.;

Cytological indicators: cell doubling time, adhesion rate, clonal formation rate, viability and morphological consistency;

Specific application indicators: such as stem cell pluripotency maintenance, primary cell separation efficiency, and hybridoma antibody secretion.

It should be noted that the indicators concerned by different laboratories differ greatly, and it is not appropriate to judge the quality of serum only by a single parameter.Internal controls and acceptance criteria should be established in conjunction with commonly used cell lines and key experimental endpoints.

III. Batch Validation and Switching Process

The laboratory can reduce the risk by "sample verification — parallel contrast — gradient mixing — formal switching".After the new batch arrives, start with less

Comments2

Sign in to comment on this article

S
SampleLine28682026-09-06 19:10

我们实验室常备两个品牌血清,一批异常马上切换,质控策略里留后手很重要。

赵
赵佳宇2026-09-11 01:55

批次差异真能逼疯人,同一株细胞换个批次增殖就掉一半,现在每次都先做小规模质控。

✉Email 💬Message 👤Member
↑Top